Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP238952.RARpw8VAx2lreBH3MmEILL5mXEpdMdQMIH5D7rKqCPb9g130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238952.RARpw8VAx2lreBH3MmEILL5mXEpdMdQMIH5D7rKqCPb9g130_provenance.
• NP332102.RAR1iOo8aUMO76hQjV643fo_tnyjlI29DbHmLQ9ExITgA130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332102.RAR1iOo8aUMO76hQjV643fo_tnyjlI29DbHmLQ9ExITgA130_provenance.
• NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
• NP772823.RAWUg7QnKb0gd8P3tZM-mVRjH_UABGwCtTBIqdIh4vTXI130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772823.RAWUg7QnKb0gd8P3tZM-mVRjH_UABGwCtTBIqdIh4vTXI130_provenance.
• NP654799.RA4R4hY8FIq5waQP8nquHn6NnghP5BybfmnBoARFhNlEY130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654799.RA4R4hY8FIq5waQP8nquHn6NnghP5BybfmnBoARFhNlEY130_provenance.
• NP909846.RA74gvkQdvdQqHtM7mOhfFm8UEM9QBgYHP-s6v5NWNxuE130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909846.RA74gvkQdvdQqHtM7mOhfFm8UEM9QBgYHP-s6v5NWNxuE130_provenance.
• NP869182.RAYcZg3y0EGUGnuqO8B9pmSpZaxQ4CMco0X67le07-t3M130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869182.RAYcZg3y0EGUGnuqO8B9pmSpZaxQ4CMco0X67le07-t3M130_provenance.
• assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP339011.RAep7D29zBoaDAKscSTzRGoReyldRLf0dcNeoh52mmbuc130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339011.RAep7D29zBoaDAKscSTzRGoReyldRLf0dcNeoh52mmbuc130_provenance.
• NP339014.RAXkoekg1ucdtAATLNNl_Rusl4hfkmN2WsNcxqPoiNxEM130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339014.RAXkoekg1ucdtAATLNNl_Rusl4hfkmN2WsNcxqPoiNxEM130_provenance.
• NP869336.RA_idPeOT-zycDeC4M-HTy4uPjoOqo-8n0dLNotWy7Teo130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869336.RA_idPeOT-zycDeC4M-HTy4uPjoOqo-8n0dLNotWy7Teo130_provenance.
• NP339012.RA38bCUqfeq3tA8EpPbxlMvyjh2N6N5rrDnWvK3GhVpb0130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339012.RA38bCUqfeq3tA8EpPbxlMvyjh2N6N5rrDnWvK3GhVpb0130_provenance.
• NP339016.RAzzZXQ578_6mcZhdb2Z97HneSXdItlqXgx-nHrgUdlXs130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339016.RAzzZXQ578_6mcZhdb2Z97HneSXdItlqXgx-nHrgUdlXs130_provenance.